ArticleActa pharmaceutica Sinica. B2026

Optimizing pyrazine-2-carboxamide derivatives as dual FLT3/HDAC inhibitors with enhanced pharmacokinetics and immunotherapeutic potential.

Yingjie Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.